Publication — IRIC
Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.
Resistance to apoptosis induced by anti-cancer drugs is a major obstacle for the treatment of aggressive forms of breast cancer. Galectin-7 (gal-7) was recently shown to be specifically expressed in basal-like but not in luminal subtypes of human breast cancer.